Similar Papers

Paper Title
Journal
Date
Author
Postischemic acute renal failure is reduced by short-term statin treatment in a rat model.
Faikah Gueler ... Jan Menne
Journal of the American Society of Nephrology | VOL. 13
Faikah Gueler, et. al.Faikah Gueler ... Jan Menne
01 Sep 2002
Gentamicin effects on renal ischemia/reperfusion injury.
R A Zager
Circulation Research | VOL. 70
R A ZagerR A Zager
01 Jan 1992
Recovery from postischemic acute renal failure in the rat
William F Finn ... Robert L Chevalier
Kidney International | VOL. 16
William F Finn, et. al.William F Finn ... Robert L Chevalier
01 Aug 1979
A role for endothelin in the maintenance of post‐ischaemic renal failure in the rat.
A López‐Farré ... D Gómez‐Garre
The Journal of Physiology | VOL. 444
A López‐Farré, et. al.A López‐Farré ... D Gómez‐Garre
01 Dec 1991
View more papers

More From: Cardiovascular Drugs and Therapy

Paper Title
Journal
Date
Author
The Combined Empagliflozin and Sacubitril/Valsartan Therapy Attenuates Isoproterenol-Induced Heart Failure in Rats: Functional, Molecular, and Structural Insights.
Maja Muric ... Vladimir Jakovljevic
Cardiovascular drugs and therapy | VOL. -
Maja Muric, et. al.Maja Muric ... Vladimir Jakovljevic
06 Feb 2025
Doxorubicin-Induced Cardiotoxicity: Can Andrographolide Provide a Silver Lining?
Mohit M Hulsurkar ... Xander H T Wehrens
Cardiovascular drugs and therapy | VOL. -
Mohit M Hulsurkar, et. al.Mohit M Hulsurkar ... Xander H T Wehrens
06 Feb 2025
Safety Analysis of Spironolactone Use in Patients Undergoing Percutaneous Coronary Intervention with High Bleeding Risk: A Propensity Score-Matched Study.
Junyan Zhang ... Yong He
Cardiovascular drugs and therapy | VOL. -
Junyan Zhang, et. al.Junyan Zhang ... Yong He
05 Feb 2025
Beta-blockers and Myocardial Infarction: to β -block or not to β -block.
Muhammad Rayan Syed ... Kashaf Iman
Cardiovascular drugs and therapy | VOL. 39
Muhammad Rayan Syed, et. al.Muhammad Rayan Syed ... Kashaf Iman
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.